U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C35H49NO10
Molecular Weight 643.7643
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of NA-808

SMILES

[H][C@@](\C=C\CCCCCCC(=O)CCCCCCC)(C(=O)N[C@@H](CC1=CC=C(OCC#CC)C=C1)C(O)=O)[C@@](O)(CC(O)=O)C(O)=O

InChI

InChIKey=RZHKGHCZVMTIDL-XSRFUOEWSA-N
InChI=1S/C35H49NO10/c1-3-5-7-10-13-16-27(37)17-14-11-8-9-12-15-18-29(35(45,34(43)44)25-31(38)39)32(40)36-30(33(41)42)24-26-19-21-28(22-20-26)46-23-6-4-2/h15,18-22,29-30,45H,3,5,7-14,16-17,23-25H2,1-2H3,(H,36,40)(H,38,39)(H,41,42)(H,43,44)/b18-15+/t29-,30+,35+/m1/s1

HIDE SMILES / InChI

Molecular Formula C35H49NO10
Molecular Weight 643.7643
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 1
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 11:32:26 GMT 2023
Edited
by admin
on Sat Dec 16 11:32:26 GMT 2023
Record UNII
KG6QPD6JM9
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NA-808
Code English
CH-4630808
Code English
(2S)-2-((E,1S)-1-(((1S)-1-((4-BUT-2-YNOXYPHENYL)METHYL)-2-HYDROXY-2-OXO-ETHYL)CARBAMOYL)-10-OXO-HEPTADEC-2-ENYL)-2-HYDROXY-BUTANEDIOIC ACID
Systematic Name English
CH4630808
Code English
D-ERYTHRO-PENTONIC ACID, 5-(((1S)-2-(4-(2-BUTYNYLOXY)PHENYL)-1-CARBOXYETHYL)AMINO)-3-C-CARBOXY-2,4,5-TRIDEOXY-5-OXO-4-(9-OXO-1-HEXADECENYL)-
Systematic Name English
D-ERYTHRO-PENTONIC ACID, 5-(((1S)-2-(4-(2-BUTYN-1-YLOXY)PHENYL)-1-CARBOXYETHYL)AMINO)-3-C-CARBOXY-2,4,5-TRIDEOXY-5-C-OXO-4-((1E)-9-OXO-1-HEXADECEN-1-YL)-
Systematic Name English
NA808
Code English
Code System Code Type Description
CAS
827034-92-4
Created by admin on Sat Dec 16 11:32:26 GMT 2023 , Edited by admin on Sat Dec 16 11:32:26 GMT 2023
PRIMARY
PUBCHEM
5278643
Created by admin on Sat Dec 16 11:32:26 GMT 2023 , Edited by admin on Sat Dec 16 11:32:26 GMT 2023
PRIMARY
FDA UNII
KG6QPD6JM9
Created by admin on Sat Dec 16 11:32:26 GMT 2023 , Edited by admin on Sat Dec 16 11:32:26 GMT 2023
PRIMARY
SMS_ID
300000042534
Created by admin on Sat Dec 16 11:32:26 GMT 2023 , Edited by admin on Sat Dec 16 11:32:26 GMT 2023
PRIMARY
CAS
744208-75-1
Created by admin on Sat Dec 16 11:32:26 GMT 2023 , Edited by admin on Sat Dec 16 11:32:26 GMT 2023
NON-SPECIFIC STEREOCHEMISTRY
Related Record Type Details
ACTIVE MOIETY
Class: Small molecule; Mechanism of Action: Hepatitis C virus replication inhibitor; Highest Development Phase: Preclinical for Hepatitis C; Most Recent Events: 23 Aug 2012 Preclinical development is ongoing in Japan, 03 Apr 2009 Preclinical development is ongoing in Japan, 09 Dec 2005 Preclinical trials in Hepatitis C in Japan (unspecified route)